Company Overview

Company name: Cannamedical Pharma
Description: Wholesaler of medical cannabis intended to help patients with chronic illnesses by importing and processing medicinal cannabis. The company provides a unique range of medical marijuana products and medicines, enabling doctors, healthcare professionals, and pharmacists to improve the quality of their patients’ lives.
Year founded: 2016
Parent company:
Industry: Healthcare | Group: | Code:
Employees: 50
City: Cologne
Country: Germany

Financial Highlights

Start up capital raised (USD Million): 30.20
Business status: Generating Revenue
Ownership: Privately Held (backing)
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Enterprise value:
Earnings before interest, tax, depreciation and amortization (EBITDA):
Fiscal period: FY 2018
Financing Status: The company raised EUR 12 million of angel funding in a deal led by Steve Wiggins on April 19, 2020. Other undisclosed investors also participated in the round. The funds will be used for key strategic growth initiatives including domestic and European expansion to promote the company’s market-leading product portfolio.
Number of active investors:
Profile last updated: 12-May-2020
Last known valuation:
Last known valuation date: 29-Jan-2019